Formulations of Viloxazine
Supernus Pharmaceuticals, Inc.
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application 61/596,458, filed Feb 8, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,358,204 | Formulations of Viloxazine In force · High confidence | Supernus Pharmaceuticals, Inc. | In force | High confidence | ||
| US 9,603,853 | Formulations of Viloxazine In force · High confidence | Supernus Pharmaceuticals, Inc. | In force | High confidence | ||
| US 10,265,319 | Formulations of Viloxazine In force · High confidence | Supernus Pharmaceuticals, Inc. | In force | High confidence | ||
| US 9,662,338 | Formulations of Viloxazine In force · High confidence | Supernus Pharmaceuticals, Inc. | In force | High confidence | ||
| Application 16/297,194 | Formulations of Viloxazine Pending Not granted | Supernus Pharmaceuticals, Inc. | Pending | Not granted | ||
| Application 18/232,716 | Formulations of Viloxazine Abandoned Abandoned Jul 10, 2025 | Supernus Pharmaceuticals, Inc. | Abandoned | Abandoned Jul 10, 2025 | ||
| Application 19/093,755 | Formulations of Viloxazine Pending Not granted | Supernus Pharmaceuticals, Inc. | Pending | Not granted | ||
| Application 19/171,852 | Formulations of Viloxazine Pending Not granted | Supernus Pharmaceuticals, Inc. | Pending | Not granted | ||
| Application 19/306,464 | Formulations of Viloxazine Pending Not granted | Supernus Pharmaceuticals, Inc. | Pending | Not granted |
9 of 9 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Supernus Pharmaceuticals, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.